Digital measures have the potential to form part of clinical development programs, but there are still a lot of questions to be addressed before this becomes a reality for sponsors and CROs. This series of 2 meetings to discuss in detail with other thought leaders the main challenges to successfully include digital measures in clinical trials and how to address these:
SESSION 1: 10th June
-Selection of digital measures for clinical trials - challenges and gaps seen so far
-Digital measures currently being used
SESSION 2: 1st July
-Development of new digital measures and safety and efficacy assessment of these